These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 26059880)
1. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4. Chen SR; Yang LQ; Chong YT; Jie YS; Wu YK; Yang J; Lin GL; Li XH Intern Med J; 2015 Jun; 45(6):672-6. PubMed ID: 26059880 [TBL] [Abstract][Full Text] [Related]
2. SLC40A1-related hemochromatosis associated with a p.Y333H mutation in mainland China: a pedigree report and literature review. Li Y; Duan F; Yang S BMC Med Genomics; 2024 Jun; 17(1):161. PubMed ID: 38886778 [TBL] [Abstract][Full Text] [Related]
3. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China. Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J; Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107 [TBL] [Abstract][Full Text] [Related]
4. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature. Zhang W; Lv T; Huang J; Ou X Medicine (Baltimore); 2017 Sep; 96(38):e8064. PubMed ID: 28930842 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation. Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651 [TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical heterogeneity of ferroportin disease. Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644 [TBL] [Abstract][Full Text] [Related]
7. Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism. Honma Y; Karasuyama T; Kumamoto K; Shimajiri S; Toki Y; Tatsumi Y; Sumida K; Koikawa K; Morino K; Oe S; Miyagawa K; Yamasaki M; Shibata M; Abe S; Ikuta K; Hayashi H; Harada M Med Mol Morphol; 2021 Mar; 54(1):60-67. PubMed ID: 32607777 [TBL] [Abstract][Full Text] [Related]
8. Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports. Wu LY; Song ZY; Li QH; Mou LJ; Yu YY; Shen SS; Song XX Medicine (Baltimore); 2021 Apr; 100(13):e25258. PubMed ID: 33787609 [TBL] [Abstract][Full Text] [Related]
9. Ferroportin Disease Caused by a Heterozygous Variant p.Cys326Phe in the SLC40A1 Gene and the Efficacy of Therapeutic Phlebotomy in Children. Shimura M; Nishimata S; Saito N; Tsutsumi N; Suzuki S; Morishima Y; Kashiwagi Y; Numabe H; Kawashima H J Pediatr Hematol Oncol; 2019 Jul; 41(5):e325-e328. PubMed ID: 30130274 [TBL] [Abstract][Full Text] [Related]
10. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV. Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113 [TBL] [Abstract][Full Text] [Related]
11. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype. Lee PL; Gelbart T; West C; Barton JC Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene]. Vargas JA; Muñoz A; Samper B; Bornstein B Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019 [No Abstract] [Full Text] [Related]
14. A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. Yamakawa N; Oe K; Yukawa N; Murakami K; Nakashima R; Imura Y; Yoshifuji H; Ohmura K; Miura Y; Tomosugi N; Kawabata H; Takaori-Kondo A; Mimori T Intern Med; 2016; 55(18):2697-701. PubMed ID: 27629970 [TBL] [Abstract][Full Text] [Related]
15. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924 [TBL] [Abstract][Full Text] [Related]
16. Identification of hereditary hemochromatosis pedigrees and a novel SLC40A1 mutation in Chinese population. An P; Jiang L; Guan Y; Wang H; Wang J; Tian Y; Yang W; Shi Y; Xue J; Min J; Wang F Blood Cells Mol Dis; 2017 Mar; 63():34-36. PubMed ID: 28110135 [No Abstract] [Full Text] [Related]
17. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia. Saja K; Bignell P; Robson K; Provan D Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395 [No Abstract] [Full Text] [Related]
18. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro. Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245 [TBL] [Abstract][Full Text] [Related]
20. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report. Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]